RPG Life Sciences
add_icon

RPG Life Sciences

2,782.70
-29.30
(-1.04%)
Market Cap
4,602.31 Cr
PE Ratio
38.92
Volume
11,654.00
Day High - Low
2,844.00 - 2,745.00
52W High-Low
3,082.00 - 1,733.00
ann
There are new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
4,602.31 Cr
EPS
69.64
PE Ratio
38.92
PB Ratio
7.69
Book Value
366.01
EBITDA
172.70
Dividend Yield
0.85 %
Industry
Healthcare
Return on Equity
19.03
Debt to Equity
0.02
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
RPG Life Sciences eyes API portfolio acquisitions6 days ago
RPG Life Sciences is looking to make more acquisitions to expand its API portfolio over the next 12 months, according to a newspaper report.
neutral
RPG Life Sciences Limited will host a virtual investor and analyst call on September 3, 2026, at 4:00 pm IST. The meeting follows the company's strategic announcement and board outcome released on September 2. Dial-in details will be shared separately.
positive
RPG Life Sciences completes API business subsidiarization into RPG Active Pharma, bringing in InvAscent as a 40% partner for ₹243.33 crore. The new entity also acquires Actis Generics and Raghava Life Sciences to boost capacity.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,861.00
#1 4,46,516.24
37.00
#1 61,673.90
12.69
#1 11,565
26.53
37.54
9,438.50
2,50,562.52
86.07
11,067.00
13.95
2,568
65.50
68.10
4,930.00
1,87,521.35
87.01
13,886.20
20.34
2,138
3.28
49.59
1,117.80
1,12,476.84
24.52
27,657.90
17.64
5,026
-34.90
45.32
1,373.30
1,10,941.40
32.93
29,044.60
2.24
3,870
-39.18
36.94
1,945.00
1,05,002.11
95.80
6,867.80
22.01
890
#1 123.93
65.88
1,668.40
95,996.05
26.21
34,145.20
5.56
3,503
25.21
55.21
1,143.00
95,402.67
29.97
35,058.60
3.90
4,158
-69.10
37.74
2,077.80
95,003.78
#1 17.23
29,038.90
#1 26.75
5,356
16.00
22.60
2,238.40
92,445.02
45.27
14,636.40
14.85
1,938
29.13
30.12

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
10.06 %
Net Income Growth
-37.12 %
Cash Flow Change
-27.43 %
ROE
-44.90 %
ROCE
-43.50 %
EBITDA Margin (Avg.)
-8.97 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
176
258
174
197
183
190
200
Expenses
124
118
133
143
149
144
152
EBITDA
53
140
41
55
35
46
48
Operating Profit %
28 %
18 %
21 %
21 %
17 %
19 %
22 %
Depreciation
6
5
5
5
5
6
6
Interest
0
0
0
0
0
0
1
Profit Before Tax
47
135
35
50
29
40
42
Tax
12
18
9
13
7
10
11
Net Profit
35
117
26
37
22
30
31
EPS in ₹
21.12
70.96
15.90
22.28
13.38
18.08
18.60

Balance Sheet

Balance Sheet
2025
2026
Total Assets
658
793
Fixed Assets
172
197
Current Assets
465
560
Capital Work in Progress
16
23
Investments
127
85
Other Assets
343
488
Total Equity & Liabilities
658
793
Current Liabilities
120
161
Non Current Liabilities
7
27
Total Equity
531
605
Reserve & Surplus
517
592
Share Capital
13
13

Cash Flow

Cash Flow
2025
2026
Net Cash Flow
9
122
Investing Activities
-42
86
Operating Activities
78
57
Financing Activities
-27
-21

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
72.07 %
72.07 %
72.07 %
72.07 %
72.07 %
72.41 %
72.61 %
72.61 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.95 %
72.95 %
72.95 %
72.95 %
72.95 %
72.95 %
72.95 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.46 %
0.56 %
0.89 %
1.14 %
1.35 %
1.30 %
1.45 %
1.35 %
1.11 %
1.00 %
0.87 %
0.95 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
2.04 %
2.02 %
2.12 %
2.29 %
3.59 %
3.79 %
4.19 %
4.63 %
5.45 %
6.06 %
6.14 %
6.48 %
6.70 %
7.04 %
7.45 %
8.67 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.45 %
20.59 %
20.58 %
20.65 %
20.85 %
20.37 %
19.91 %
20.26 %
19.91 %
19.45 %
18.41 %
18.16 %
17.41 %
16.79 %
15.92 %
15.58 %
15.33 %
15.46 %
15.37 %
15.17 %
14.98 %
13.88 %
Others
7.47 %
7.33 %
7.34 %
7.28 %
7.07 %
7.21 %
5.44 %
5.10 %
5.16 %
5.45 %
4.73 %
4.67 %
4.70 %
4.62 %
4.47 %
4.11 %
4.12 %
3.76 %
3.88 %
3.83 %
3.74 %
3.54 %
No of Share Holders
18,701
20,564
23,674
22,768
22,821
22,115
20,757
21,360
20,837
20,226
21,088
21,866
22,137
22,232
23,481
24,891
24,867
25,832
26,657
25,905
25,282
23,886

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 2.8 2.4 2.4 4 7.2 9.6 12 16 24 24
Dividend Yield (%) 0.73 0.97 1.41 1.03 1.28 1.4 0.79 0.7 1.29 0.85

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 Aug 2021 DIVIDEND Dividend
7.20 /share
13 Aug 2021 490.80 516.85
15 Jul 2022 DIVIDEND Dividend
9.60 /share
14 Jul 2022 589.35 568.55
21 Jul 2023 DIVIDEND Dividend
12.00 /share
21 Jul 2023 820.55 996.65
28 Jun 2024 DIVIDEND Dividend
16.00 /share
28 Jun 2024 1,560.55 1,599.95
16 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Jul 2024 1,535.60 1,640.55
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 2,443.95 2,673.90
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 2,067.10 2,166.65
28 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Apr 2025 2,197.25 2,244.30
27 Jun 2025 DIVIDEND Dividend
20.00 /share
27 Jun 2025 2,244.30 2,424.10
27 Jun 2025 DIVIDEND Dividend
4.00 /share
27 Jun 2025 2,244.30 2,424.10
16 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Jul 2025 2,341.50 2,557.00
25 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Jul 2025 2,548.80 2,515.25
17 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 Oct 2025 2,234.25 2,306.00
27 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Jan 2026 2,295.45 2,135.40
29 Apr 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Apr 2026 1,998.70 2,058.75
09 Jul 2026 DIVIDEND Dividend
24.00 /share
09 Jul 2026 2,058.75 2,458.25
23 Jul 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Jul 2026 2,277.65 3,005.50
28 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jul 2026 3,018.35 2,928.10

Announcements

Update On Investment And Shareholder Agreement1 day ago
Outcome Of Investors Meet6 days ago
Investors Meet7 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
Intimation Of Execution Of BTA By RPG Active Pharma Limited (WOS) With Raghava Life Sciences Private Limited8 days ago
Outcome Of Board Meeting8 days ago
Cancellation Of Investor Meet9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 25, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 20, 2026
Announcement under Regulation 30 (LODR)-CessationAug 15, 2026
Update On API Business Transfer AgreementAug 15, 2026
RPG Life Sciences Limited Has Informed The Exchange About Further Investment In RPG Active Pharma LimitedAug 15, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 10, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 31, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 29, 2026
Announcement under Regulation 30 (LODR)-AcquisitionJul 29, 2026
Announcement under Regulation 30 (LODR)-RestructuringJul 29, 2026
Outcome Of Board Meeting Held Today July 29 2026Jul 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJul 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 28, 2026
Unaudited Financial Results For The Quarter Ended June 30 2026Jul 28, 2026
Board Meeting Outcome for Outcome Of Board MeetingJul 28, 2026
Announcement under Regulation 30 (LODR)-CessationJul 27, 2026
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 23, 2026
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 23, 2026
Board Meeting Intimation for Financial Result For Quarter Ended June 2026Jul 21, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 13, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 02, 2026
Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The CompanyJul 02, 2026
Business Responsibility and Sustainability Reporting (BRSR)Jul 01, 2026
Notice Of 19Th Annual General Meeting Of The CompanyJul 01, 2026
Reg. 34 (1) Annual Report.Jul 01, 2026
Closure of Trading WindowJun 25, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 23, 2026
Record Date For Determining Members Eligible To Receive Dividend For The Financial Year 2025-26.Jun 22, 2026
Clarification For Volume Movement LetterJun 12, 2026
Clarification sought from RPG Life Sciences LtdJun 12, 2026
Communication To Shareholders - Intimation On Dividend Taxation ProvisionsJun 09, 2026
Intimation To Shareholders Holding Shares In Physical Form For Furnishing KYC DetailsJun 09, 2026
General UpdateJun 03, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 25, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 30, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Unifi Flexi Cap Fund Direct-Growth
0.00%
-6565
-0.80%
-0.75%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-13
-0.01%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
0
0.00%
-0.07%
Mirae Asset Multicap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Quant Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Quant Multi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Union Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
60.72
ATR(14)
Volatile
113.00
STOCH(9,6)
Neutral
70.64
STOCH RSI(14)
Overbought
92.41
MACD(12,26)
Bullish
22.21
ADX(14)
Weak Trend
20.17
UO(9)
Bearish
44.38
ROC(12)
Uptrend And Accelerating
7.19
WillR(14)
Neutral
-31.77